Search by Drug Name or NDC

    NDC 00002-7728-99 LYUMJEV 100 [iU]/mL Details

    LYUMJEV 100 [iU]/mL

    LYUMJEV is a INTRAVENOUS; SUBCUTANEOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Eli Lilly and Company. The primary component is INSULIN LISPRO.

    Product Information

    NDC 00002-7728
    Product ID 0002-7728_6f84ba56-a2a5-440e-9d3f-334655934a53
    Associated GPIs 27104005052020
    GCN Sequence Number 081183
    GCN Sequence Number Description insulin lispro-aabc VIAL 100/ML SUBCUT
    HIC3 C4G
    HIC3 Description INSULINS
    GCN 48226
    HICL Sequence Number 046616
    HICL Sequence Number Description INSULIN LISPRO-AABC
    Brand/Generic Brand
    Proprietary Name LYUMJEV
    Proprietary Name Suffix n/a
    Non-Proprietary Name Insulin lispro-aabc
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SOLUTION
    Route INTRAVENOUS; SUBCUTANEOUS
    Active Ingredient Strength 100
    Active Ingredient Units [iU]/mL
    Substance Name INSULIN LISPRO
    Labeler Name Eli Lilly and Company
    Pharmaceutical Class Insulin Analog [EPC], Insulin [Chemical/Ingredient]
    DEA Schedule n/a
    Marketing Category BLA
    Application Number BLA761109
    Listing Certified Through 2024-12-31

    Package

    NDC 00002-7728-99 (00002772899)

    NDC Package Code 0002-7728-99
    Billing NDC 00002772899
    Package 1 VIAL, MULTI-DOSE in 1 CARTON (0002-7728-99) / 10 mL in 1 VIAL, MULTI-DOSE
    Marketing Start Date 2020-06-15
    NDC Exclude Flag N
    Pricing Information N/A